KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2025)

CRISPR Therapeutics AG's Asset Utilization Ratio history spans 10 years, with the latest figure at 0.0 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 90.62% year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, down 90.62%, while the annual FY2025 figure was 0.0, 90.67% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.0 at CRISPR Therapeutics AG, down from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.37 in Q2 2021 and bottomed at 0.0 in Q4 2022.
  • The 5-year median for Asset Utilization Ratio is 0.06 (2023), against an average of 0.11.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 75541.13% in 2021 before it plummeted 99.84% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.33 in 2021, then tumbled by 99.84% to 0.0 in 2022, then surged by 32895.55% to 0.17 in 2023, then crashed by 90.35% to 0.02 in 2024, then crashed by 90.62% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for CRSP's Asset Utilization Ratio are 0.0 (Q4 2025), 0.02 (Q3 2025), and 0.02 (Q2 2025).